Diltiazem hydrochloride and Aortic thrombosis - a phase IV clinical study of FDA data


Aortic thrombosis is reported only by a few people who take Diltiazem Hydrochloride.

The phase IV clinical study analyzes which people take Diltiazem hydrochloride and have Aortic thrombosis. It is created by eHealthMe based on reports of 10,550 people who have side effects while taking Diltiazem hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 01, 2023

10,550 people reported to have side effects when taking Diltiazem hydrochloride.
Among them, 5 people (0.05%) have Aortic thrombosis.

What is Diltiazem hydrochloride?

Diltiazem hydrochloride has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 12,005 Diltiazem hydrochloride users for its effectiveness, alternative drugs and more.

What is Aortic thrombosis?

Aortic thrombosis (formation of a blood clot inside aorta) is found to be associated with 585 drugs and 293 conditions by eHealthMe.

Number of Diltiazem hydrochloride and Aortic thrombosis reports submitted per year:

Could Diltiazem hydrochloride cause Aortic thrombosis?

Gender of people who have Aortic thrombosis when taking Diltiazem hydrochloride *:

  • female: 40 %
  • male: 60 %

Age of people who have Aortic thrombosis when taking Diltiazem hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Diltiazem hydrochloride *:

  1. Timolol Maleate: 2 people, 40.00%
  2. Mektovi: 2 people, 40.00%
  3. Lipitor: 2 people, 40.00%
  4. Latanoprost: 2 people, 40.00%
  5. Braftovi: 2 people, 40.00%
  6. Xeloda: 1 person, 20.00%
  7. Ondansetron: 1 person, 20.00%
  8. Emend: 1 person, 20.00%
  9. Dipyridamole: 1 person, 20.00%
  10. Amlodipine: 1 person, 20.00%

Common side effects people have besides Aortic thrombosis *:

  1. Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 2 people, 40.00%
  2. Renal Cyst (kidney cyst): 2 people, 40.00%
  3. Cardiac Failure: 2 people, 40.00%
  4. Aortic Aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall): 2 people, 40.00%
  5. Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls): 1 person, 20.00%
  6. Vascular Calcification (deposits of calcium in the blood vessels): 1 person, 20.00%
  7. Peripheral Artery Aneurysm (bulge or ""ballooning"" in the wall of peripheral artery): 1 person, 20.00%

Common conditions people have *:

  1. Colon Cancer: 3 people, 60.00%
  2. Ill-Defined Disorder: 2 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take Diltiazem hydrochloride and have Aortic thrombosis?

Check whether Aortic thrombosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Aortic thrombosis and when was it recovered:

Expand to all the drugs that have ingredients of diltiazem hydrochloride:

Alternative drugs to, pros and cons of Diltiazem hydrochloride:

Common Diltiazem hydrochloride side effects:

Browse all side effects of Diltiazem hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Aortic thrombosis treatments and more:

COVID vaccines that are related to Aortic thrombosis:

Common drugs associated with Aortic thrombosis:

All the drugs that are associated with Aortic thrombosis:

All the conditions that are associated with Aortic thrombosis:

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride (the active ingredients of Diltiazem hydrochloride) and Diltiazem hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: